A parliamentary health committee has announced an inquiry into treatment, testing, prevention and the cost of hepatitis C in Australia.
The inquiry will include two round tables with community support groups and medical experts early next year.
There are currently 230,000 people in Australia living with chronic hepatitis C infection, but it is estimated that only 1 per cent receive treatment annually.
Helen Tyrrell, chief executive of Hepatitis Australia, believes that the inquiry could be a turning point in the battle against hepatitis C in Australia.
For more information, please visit The Sydney Morning Herald.